BROWSE

Related Scientist

Researcher

복잡계 자기조립 연구단
복잡계 자기조립 연구단
more info

Novel Fabrication of MicroRNA Nanoparticle-Coated Coronary Stent for Prevention of Post-Angioplasty Restenosis

Cited 5 time in webofscience Cited 0 time in scopus
67 Viewed 1 Downloaded
Title
Novel Fabrication of MicroRNA Nanoparticle-Coated Coronary Stent for Prevention of Post-Angioplasty Restenosis
Author(s)
Che, HL; Bae, IH; Lim, KS; Uthaman, S; Song, IT; Lee, H; Duhwan Lee; Won Jong Kim; Ahn, Y; Park, IK; Jeong, MH
Publication Date
2016-01
Journal
KOREAN CIRCULATION JOURNAL, v.46, no.1, pp.23 - 32
Publisher
KOREAN SOC CARDIOLOGY
Abstract
Background and Objectives: MicroRNA 145 is known to be responsible for cellular proliferation, and its enhanced expression reportedly inhibits the retardation of vascular smooth muscle cell growth specifically. In this study, we developed a microRNA 145 nanoparticle immobilized, hyaluronic acid (HA)-coated stent. Materials and Methods: For the gene therapy, we used disulfide cross-linked low molecular polyethylenimine as the carrier. The microRNA 145 was labeled with YOYO-1 and the fluorescent microscopy images were obtained. The release of microRNA 145 from the stent was measured with an ultra violet spectrophotometer. The downstream targeting of the c-Myc protein and green fluorescent protein was determined by Western blotting. Finally, we deployed microRNA 145/ssPEl nanoparticles immobilized on HA -coated stents in the balloon injured external iliac artery in a rabbit restenosis model. Results: Cellular viability of the nanoparticle-immobilized surface tested using A10 vascular smooth muscle cells showed that MSN exhibited negligible cytotoxicity. In addition, microRNA 145 and downstream signaling proteins were identified by western blots with smooth muscle cell.(SMC) lysates from the transfected A10 cell, as the molecular mechanism for decreased SMC proliferation that results in the inhibition of in-stent restenosis. MicroRNA 145 released from the stent suppressed the growth of the smooth muscle at the peristent implantation area, resulting in the prevention of restenosis at the post-implantation. We investigated the qualitative analyses of instent restenosis in the rabbit model using micro-computed tomography imaging and histological staining. Conclusion: MicroRNA 145-eluting stent mitigated in-stent restenosis efficiently with no side effects and can be considered a successful substitute to the current drug-eluting stent Copyright © 2016 The Korean Society of Cardiology
URI
http://pr.ibs.re.kr/handle/8788114/4845
DOI
10.4070/kcj.2016.46.1.23
ISSN
1738-5520
Appears in Collections:
Center for Self-assembly and Complexity(복잡계 자기조립 연구단) > Journal Papers (저널논문)
Files in This Item:
2ff322a709afd625b316e638f4277959307c.pdfDownload

qrcode

  • facebook

    twitter

  • Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse